• Type: Seminar Series
• Series organisers: Fiona Lambert (University of Oxford, MRC Weatherall Institute of Medicine) , Emma Butterfield (MRC Weatherall Institute of Molecular Medicine) , Beatriz Hirt-Font (University of Oxford, MRC Weatherall Institute of Molecular Medicine)
• Timing: Tuesdays at 1.00 pm
• Organising department: MRC Molecular Haematology Unit

Tuesday 7 January 2025

• 13:00 - Unlocking the potential of a pleiotropic cytokine
  This is a hybrid event - with the speaker attending in-person and viewable on Teams.
  Dr. Ian Hitchcock (Department of Biology, University of York)

Wednesday 8 January 2025

• 11:00 - "Bookending” leukaemia: the Alpha and Omega of AML evolution.
  This is a hybrid event - with the speaker attending in-person and viewable on Teams.
  Prof Brian Huntly (University of Cambridge)

Tuesday 21 January 2025

• 13:00 - Stressed hematopoiesis yields somatic rescue and secondary leukemia
  This is a hybrid event - with the speaker attending in-person and viewable on Teams.
  Professor Jean Soulier (Saint-Louise Hospital, France)

Tuesday 11 February 2025

• 13:00 - Somatic phylogenies of haematopoietic stem cells to study clonal dynamics and mutagenesis
  This is a hybrid event - with the speaker attending in-person and viewable on Teams.
  Dr Mike Spencer Chapman (Director of Research and Clinical Trials, NHS Digital)

Tuesday 4 March 2025

• 13:00 - Title TBC
  This is a hybrid event - with the speaker attending in-person and viewable on Teams.
  Dr Simon Bomken (Newcastle University)

Tuesday 18 March 2025

• 13:00 - Title TBC
  This is a hybrid event - with the speaker attending in-person and viewable on Teams.
  Dr Michael Milsom (German Cancer Research Centre)

Tuesday 1 April 2025

• 13:00 - Title TBC
  This is a hybrid event - with the speaker attending in-person and viewable on Teams.
  Professor George Vassilou (Cambridge Cancer Stem Cell Institute)

Tuesday 8 April 2025

• 13:00 - Title TBC
  This is a hybrid event - with the speaker attending in-person and viewable on Teams.
  Professor Andreas Trumpp (German Cancer Research Center (DKFZ), Heidelberg)